Generic Levetiracetam Achieved By China Manufacturers
This article was originally published in PharmAsia News
Executive Summary
Type 3.1 chemical drug, levetiracetam (Keppra), APIs and tablets, from Salubris, Jingxin Pharmaceutical and Chongqing Shenghuaxi are shown as “Approved-Certification under production” on the China FDA Website, making it likely the manufacturers will make and sell the first domestic generic batches.